Abstract
In recent years, it has been proposed that tumours are not homogeneous but composed of several cellular types like normal tissues. A cellular subtype, which is though to be the origin of tumours as well as their malignant properties (i.e., capacity for regrowth and metastasis), are the cancer stem cells (CSCs). CSCs, like normal stem cells, have a nearly unlimited capacity to self-renew and to proliferate so that are responsible, besides their same auto-perpetuation giving rise to the features previously depicted, also for the generation of the bulk of more differentiated cells in tumour. The altered behaviour of CSCs may be caused by the malfunction of a number of signalling pathways involved in normal embryonic development and in tissue homeostasis in adulthood. Among these signalling pathways are Wnt, Hedgehog, Notch and BMP pathways. In this review, we will focus on the study of molecular aspects of BMP signalling as well as its involvement in cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Canalis E, Economides AN, Gazzerro E (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218–235
Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651–657
Lin SJ, Lerch TF, Cook RW et al (2006) The structural basis of TGF-protein, and activin ligand binding. Reproduction 132:179–190
Shi Y, Massagué J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700
Xiao YT, Xiang LX, Shao JZ (2007) Bone morphogenetic protein. Biochem Biophys Res Commun 362:550–553
Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65
Kochanowska I, Chaberek S, Wojtowicz A et al (2007) Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton. BMC Musculoskelet Disord 8:128–137
Varga AC, Wrana JL (2005) The disparate role of BMP in stem cell biology. Oncogene 24:5713–5721
Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231–250
Mazerbourg S, Sangkuhl K, Luo CW et al (2005) Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem 280:32122–32132
Kirkbride KC, Townsend TA, Bruinsma MW et al (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283:7628–7637
David L, Mallet C, Mazerbourg S et al (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptorlike kinase 1 (ALK1) in endothelial cells. Blood 109:1953–1961
Shi W, Chang C, Nie S et al (2007) Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci 120:1216–1224
Ross S, Hill CS (2008) How the Smads regulate transcription. Int J Biochem Cell Biol 40:383–408
Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810
Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56–61
Hogan BL (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432–438
Lamm ML, Podlasek CA, Barnett DH et al (2001) Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol 232:301–314
Grishina IB, Kim SY, Ferrara C et al (2005) BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol 288:334–347
Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22:1129–1147
Dai J, Kitagawa Y, Zhang J et al (2004) Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 64:994–999
Davies SR, Watkins G, Douglas-Jones A et al (2007) Bone morphogenic proteins 1 to 7 in human breast carcinoma. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings 25[18S], Abstract 21154
Kodach LL, Wiercinska E, de Miranda NF et al (2008) The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134:1332–1341
Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184–187
Haramis AP, Begthel H, van den Born M et al (2004) De novo crypt formation and juvenile polyposis on BMP Inhibition in mouse intestine. Science 303:1684–1686
Boulay JL, Mild G, Lowy A et al (2002) SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 87:630–634
Hardwick JC, Van Den Brink GR, Bleuming SA et al (2004) Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126:111–121
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blanco Calvo, M., Bolós Fernández, V., Medina Villaamil, V. et al. Biology of BMP signalling and cancer. Clin Transl Oncol 11, 126–137 (2009). https://doi.org/10.1007/S12094-009-0328-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/S12094-009-0328-8